Print this page

Stress and Anxiety Disorders Program

Peer-Reviewed Research Publications from the University of Michigan Anxiety Disorders Program and Trauma, Stress and Anxiety Research Group

  1. Liberzon J, Abelson JL, King A, Liberzon I: Naturalistic stress and cortisol response to awakening: Adaptation to seafaring.  Psychoneuroendocrinology 2008; 33:1023-1026.
  2. Khan S, Briggs H, & Abelson JL: Effect of time of preparation on pentagastrin-induced symptom, endocrine and cardiovascular responses.  Psychiatry Research, 2008; 158(2):141-6.
  3. Gloster AT, Richard DCS, Himle JA, Koch E, Anson H, Lokers L, & Thornton J: Accuracy of retrospective memory and covariation estimation in patients with obsessive-compulsive disorder.  Behaviour Research and Therapy, 2008; 46(5): 642-655.
  4. Muroff JR, Jackson JJ, Mowbray CT, & Himle JA: Gender, patient volume and time on clinical diagnostic decision-making in the psychiatric emergency setting (PES).  General Hospital Psychiatry, 2007; 29(6):481-8.
  5. Abelson JL, Khan S, Liberzon I, Young EA: HPA axis activity in patients with panic disorder:  Review and synthesis of four studies.  Depression & Anxiety, 2007; 24:66-76.
  6. Taylor SF and Liberzon I: Neural correlates of emotion regulation in psychopathology Trends in Cognitive Science,2007; 11(10):413-8.
  7. Seng JS, Schrot JA, & Liberzon I: Service use data analysis of pre-pregnancy psychiatric and somatic diagnoses in women with hyperemesis gravidarum. Journal of Psychsomatics,2007; 28(4):209-17.
  8. Britton JC, Ho SH, Taylor SF, Keith D, & Liberzon I: Neuroticism associated with neural activation patterns to positive stimuli. Psychiatric research: Neuroimaging,2007; 156(3):263-7.
  9. Hanna GL, Veenstra-VanderWeele J, Cox NJ, Van Etten-Lee ML, Fischer DJ, Himle JA, Bivens NC, Wu X, Roe CA, Hennessey KA, Dickel DE, Leventhal BL, & Cook EH:  Evidence for a Susceptibility Locus on Chromosome 10p15 in Early-onset obsessive-compulsive disorder.  Biological Psychiatry, 2007;62(8):856-62.
  10. Abelson JL, Khan S, Lyubkin M, & Giardino N: Respiratory irregularity and stress hormones in panic disorder: Exploring potential linkages.  Depression & Anxiety, 2007; epublished 7 Jun 2007.
  11. Liberzon I, King AP, Britton JC, Phan L, Abelson JL, Taylor SF:  Paralimbic and medial prefrontal cortical involvement in neuroendocrine responses to traumatic stimuli.  Am J Psychiatry, 2007; 164:1250-1258.
  12. Liberzon I, Taylor SF, Phan KL, Britton JC, Fig LM, Bleuller JA, Koeppe RA, & Zubieta JK: Altered Central m-Opioid Receptor Binding Following Psychological Trauma. Biological Psychiatry, 2007;61(9):1030-1038.
  13. Dickel DE, Veenstra-VanderWelle J, Bivens NC, Wu X, Fischer DJ, Van Etten-Lee M, Himle JA, Leventhal BL, Cook EH, & Hanna GL:  Association studies of serotonin system candidate genes in early-onset obsessive-compulsive disorder.  Biological Psychiatry, 2007; 61:322-329.
  14. Himle JA, Fischer DJ, Muroff JR, Van Etten ML, Lokers LM, Abelson JL, & Hanna GL:  Videoconferencing-based cognitive-behavioral treatment for obsessive-compulsive disorder.  Behavior Research and Therapy, 2006; 44:1821-1829.
  15. Liberzon I, Abelson JL, Amdur RL, King AP, Cardneau JD, Henke P, & Graham LM: Increased psychiatric morbidity after abdominal aortic surgery: Risk factors for stress-related disorders.  J Vasc Surg, 2006; 43:929-934.
  16. Taylor SF, Martis B, Fitzgerald KD, Welsh RC, Abelson JL, Liberzon I, Himle JA, & Gehring WJ:  Medical frontal cortex activity and loss-related responses to errors.  J. Neurosci, 2006; 26:4063-4070.
  17. Britton, JC, Taylor SF, Berridge KC, Mikels JA, & Liberzon I: Differential Subjective and Psychophysiological Responses to Social and Non-social Emotional Stimuli. Emotion, 2006; 6(1):150-5.
  18. Britton JC, Phan KL, Taylor SF, Welsh RC, Berridge KC, & Liberzon I:  Neural correlates of social and nonsocial emotions:  An fMRI study.  Neuroimage, 2006; 31(1):397-409.
  19. Phan KL, Britton JC, Taylor SF, Fig LM, & Liberzon I:  Cortico-Limbic Blood Flow During Non-traumatic Emotional Processing in PTSD. Archives of General Psychiatry, 2006; 63:184–192.
  20. Britton JC, Taylor SF, Keith D. Sudheimer KD, & Liberzon I:  Facial expressions and complex IAPS pictures: Common and Differential Networks. Neuroimage, 2006; 31(2):906-919.
  21. Mclean SA, Williams DA, Stein PK, Harris RE, Lyden AK, Whalen G, Park KM, Liberzon I, Seng A, Gracely RH, Baraniuk JN, & Clauw DJ:  Cerebrospinal fluid corticotrophin-releasing factor concentration is associated with pain but not fatigue symptoms in patients with fibromyalgia.  Neuropsychopharmacology, 2006; 12:2776-82.
  22. Liberzon I and Martis B: Neuroimaging studies of emotional responses in PTSD. In Psychobiology of Posttraumatic Stress Disorder: A decade of progress. AnnalsYorkAcademy of Science, 2006; 1071:87-109.
  23. Dickel DE, Veenstra-VanderWeele J, Cox NJ, Wu X, Fischer DF, Van Etten ML, Himle JA, Leventhal BL, Cook EH, & Hanna GL: Association testing of the positional and functional candidate gene SLC1A1/EAAC1 in early-onset obsessive-compulsive disorder. Archives of General Psychiatry, 2006; 63:778-785.
  24. Himle JA, Van Etten ML, Janeck AS, & Fischer DJ:  Insight as a predictor of outcome in behavioral group treatment for obsessive-compulsive disorder.  Cognitive Therapy and Research, 2006; 30:661-666.
  25. Abelson JL, Curtis GC, & Uhde TW: Twenty-four hour growth hormone secretion in patients with panic disorder.  Psychoneuroendocrinology, 2005; 30: 72-79.
  26. Fitzgerald KD, Welsh RC, Gehring WJ, Abelson JL, Himle JA, Liberzon I, & Taylor SF:  Error-related hyperactivity of the anterior cingulate cortex in obsessive compulsive disorder.  Biol Psychiatry, 2005; 57:287-294.
  27. Abelson JL, Liberzon I, Young EA, Khan S: Cognitive modulation of the endocrine stress response to a pharmacological challenge in normal and panic disorder subjects. Arch Gen Psychiatry, 2005; 62:668-675.
  28. Abelson JL, Curtis GC, Sagher O, Albucher RC, Harrigan M, Taylor SF, Martis B, & Giordani B: Deep brain stimulation for refractory obsessive compulsive disorder.  Biol Psychiatry, 2005; 57:510-516.
  29. Young EA, Abelson JL, & Cameron OG: Interaction of brain noradrenergic system and the hypothalamic-pituitary-adrenal (HPA) axis in man.  Psychoneuroendocrinology, 2005, 30:807-814.
  30. McLean SA, Clauw DJ, Abelson JL, Liberzon I: The development of persistent pain and psychological morbidity after motor vehicle collision: Integrating the potential role of stress response systems into a biopsychosocial model.  Psychosom Med, 2005; 67:783-790.
  31. Britton JC, Phan KL, Taylor SF, Fig LM, Liberzon I: Cortico-limbic Blood Flow in Posttraumatic Stress Disorder during Script Driven Imagery. Biological Psychiatry, 2005;  57(8): 832-840.
  32. Hanna GL, Fischer DJ, Chadha KR, Himle JA, & Van Etten M: Familial and sporatic subtypes of early-onset Obsessive Compulsive disorder. Biological Psychiatry, 2005; 57:895-900.
  33. Hanna GL, Fingerlin TE, Himle JA, Curtis GC, & Boehnke M: A Family Study of Obsessive-Compulsive Disorder with Pediatric Probands. American Journal of Medical Genetics, 2005; 134:13-19.
  34. Hanna GL, Fingerlin T, Himle JA, & Boehnke M: Complex segregation analysis of obsessive-compulsive disorder in families with pediatric probands. Human Heredity, 2005; 60:1-9.
  35. Khan S, Liberzon I, & Abelson JL:  Effect of repeat exposure on neuroendocrine and symptom responses to pentagastrin. Psychiatry Research, 2004; 126:189-195.
  36. Khan S, Liberzon I, & Abelson JL: Effects of propranolol on symptom and endocrine responses to pentagastrin.  Psychoneuroendocrinology, 2004; 29:1163-1171.
  37. Young EA, Abelson JL, & Cameron OG:  Effect of comorbid anxiety disorders on HPA response to a social stressor in major depression.  Biol Psychiatry, 2004; 56:113-120.
  38. Cameron OG, Abelson JL, & Young EA: Anxious and depressive disorders and their comorbidity: Effect on central nervous system noradrenergic function.  Biol Psychiatry, 2004; 56: 875-883.
  39. Young EA, Abelson JL, & Lightman SL:  Cortisol pulsatility and its role in stress regulation and health.  Front Neuroendocrinol, 2004; 25:69-76.
  40. Khan S and Liberzon I: Topiramate attenuates exaggerated acoustic startle in an animal model of PTSD. Psychopharmacolog, 2004; March 172(2):225-9.
  41. Phan KL, Taylor SF, Welsh RC, Ho SH, Britton JC, & Liberzon I: Neural correlates of individual ratings of emotional salience: a trial-related fMRI study. NeuroImage,2004; 21(2):768-780.
  42. Phan KL, Wager TD, Taylor SF, & Liberzon I:  Functional Neuroimaging Studies of Human Emotions. CNS Spectrums, 2004; 9(4):258-267.
  43. Koch EI, Spates R, & Himle JA: Comparison of Behavioral and Cognitive-Behavioral One-Session Exposure Treatments for Small Animal Phobias. Behaviour Research and Therapy, 2004; 42:1483-1504.
  44. Alpers GW, Abelson JL, Wilhelm FH, & Roth WT: Salivary cortisol responses to exposure treatment in driving phobics.  Psychosom Med, 2003; 65:679-687.
  45. Liberzon I, Phan KL, Khan S, & Abelson JL: Role of the GABA-A receptor in anxiety: Evidence from animal models, molecular and clinical psychopharmacology, and brain imaging studies.  Current Neuropharmacology, 2003; 1:267-283.
  46. Schmeelk-Cone KH, Zimmerman MA, & Abelson JL: The buffering effects of active coping on the relationship between SES and cortisol among African American young adults.  Behavioral Medicine, 2003; 29:85-94.
  47. Phan KL, Taylor SF, Welsh RC, Decker LR, Nichols TE, Noll DC, Britton JC, & Liberzon I: Activation of the Medial Prefrontal Cortex and Extended Amygdala by Individual Ratings of Emotional Arousal: An fMRI Study.  Biological Psychiatry, 2003; 53:211-215.
  48. Taylor SF, Phan KL, Decker LR, & Liberzon I:  Subjective rating of emotionally salient stimuli modulates limbic activity. NeuroImage,  2003; 18:650-659.
  49. Liberzon I, Phan KL, Decker LR, & Taylor SF: Extended amygdala and emotional salience: A PET investigation of positive and negative affect. Neuropsychopharmacology, 2003; 28:726-733.
  50. Wager TD, Phan KL, Liberzon I, & Taylor SF:  Valence, gender, and lateralization of functional brain anatomy in emotion: A meta-analysis of findings from neuroimaging. NeuroImage, 2003; 19(3):513-31.
  51. Liberzon I and Phan KL: Brain Imaging Studies of Posttraumatic Stress Disorder. CNS Spectrums, 2003; 8(9):641-650.
  52. Phan KL, Liberzon I, Welsh RC, Britton JC, & Taylor SF: Habituation of rostral anterior cingulate cortex to repeated emotional salient pictures.  Neuropsychopharmacology,  2003; 28 (7):1344-50.
  53. Liberzon I, Phan KL, & Britton JC: Neural Correlates of Symptom Provocation in Posttraumatic Stress Disorder. Stress, 2003;6(3):151-156.
  54. Himle JA, Fischer DJ, Van Etten ML, Janeck AS, & Hanna GL:  Group behavioral therapy for adolescents with tic-related and non-tic-related obsessive-compulsive disorder.  Depression and Anxiety, 2003; 17:73-78.
  55. Himle JA, Van Etten M, & Fischer DJ: Group cognitive-behavioral therapy for obsessive-compulsive disorder: A review. Brief Treatment and Crisis Intervention, 2003; 3:217-229.
  56. Liberzon I, Taylor SF, Fig LM, Phan KL, Koeppe RA, & Zubieta JK:  Mu-opioid Receptors and Limbic Responses to Aversive Emotional Stimuli. Proceedings of the NationalAcademy of Sciences of the Unites States of America (PNAS),  2002;99(10):7084-7089.
  57. Phan KL, Wager T, Taylor SF, & Liberzon I:  Functional Neuroanatomy of Emotion:  A Meta-analysis of Emotion Activation Studies in PET and fMRI.  NeuroImage, 2002;  16:331-348.
  58. Albucher RC and Liberzon I: Psychopharmacological Treatment in PTSD: a Critical Review. Journal of Psychiatric Research, 2002; 36:355-367.
  59. Hanna GL, Veenstra-Vander Weele, Cox JN, Boehnke M, Himle J, Curtis GC, Leventhal BL, & Cook EH:  Genome-Wide Linkage Analysis of Families with Obsessive-Compulsive Disorder Ascertained through Pediatric Probands. Neuropsychiatric Genetics, 2002; 114:541-552.
  60. Hanna GL, Piacentini J, Cantwell D, Fischer DJ, Himle JA, & Van Etten ML: Obsessive-compulsive disorder with and without tics in a clinical sample of children and adolescents. Depression and Anxiety, 2002; 16:59-63.
  61. Abelson JL and Young EA: Hypothalamic-pituitary adrenal response to cholecystokinin-B receptor agonism is resistant to cortisol feedback inhibition.  Psychoneuroendocrinology, 2001; 28:169-180.
  62. Abelson JL, Weg JG, Nesse RM, & Curtis GC: Persistent respiratory irregularity in patients with panic disorder.  Biol Psychiatry, 2001; 49:588-595.
  63. Abelson JL, Le Melledo JM, & Bichet DG: Dose response of arginine vasopressin to the CCK-B agonist pentagastrin. Neuropsychopharmacology, 2001; 24:161-169.
  64. Himle JA, Rassi S, Haghighatgou H, Krone KP, Nesse RM, & Abelson J: Group behavioral therapy of obsessive-compulsive disorder: Seven versus twelve week outcomes.  Anxiety and Depression, 2001; 13:161-165.
  65. Amdur RL and Liberzon I: The structure of Posttraumatic stress disorder symptoms in combat veterans: a confirmatory factor analysis of the impact of event scale. Journal of Anxiety Disorders, 2001; 15:345-357.
  66. Himle JA:  Medication consultation: The non-physician perspective.  Psychiatric Annals, 2001; 31:623-628.
  67. Gerhing WJ, Himle JA, & Neisenson LG: Action monitoring dysfunction in obsessive-compulsive disorder.  Psychological Science, 2000; 11:1-6.
  68. Huang MP, Himle J, Beier K, Alessi NE: Vivid visualization in the experience of phobia in virtual environments: Preliminary results. Cyberpsychology and Behavior, 2000; 3:315-320.
  69. Rajarethinam RP, Abelson JL, & Himle J: Acute onset and remission of obsessions and compulsions following medical illness and stress.  Anxiety and Depression, 2000; 12:238-240.
  70. Amdur RL and Liberzon I: Emotional processing in combat-related PTSD: a comparison with traumatized and normal controls. Journal of Anxiety Disorders, 2000; 14(3):219-38.
  71. Taylor SF, Liberzon I, & Koeppe RA: The effect of grade aversive stimuli on limbic and visual activation. Neuropsychologia, 2000; 38(10):1415-1425.
  72. Liberzon I, Taylor SF, Fig LM, Decker LR, Koeppe RA, & Minoshima S: Limbic activation and psychophysiological response to aversive visual stimuli: interaction with cognitive task. Neuropsychopharmacology, 2000; 23:508-16.
  73. Abelson JL and Liberzon I: Dose response of adrenocorticotropin and cortisol to the CCK-B agonist pentagastrin. Neuropsychopharmacology, 1999; 21:485-494.
  74. Himle JA, Abelson JL, Haghightgou H, Hill EM, Nesse RM, & Curtis GC: Effect of Alcohol on Social Phobic Anxiety. Am J Psychiatry, 1999; 156:1237-1243.
  75. Liberzon I, Abelson JL, Flagel SB, Raz J, & Young EA: Neuroendocrine and psychophysiologic responses in PTSD: A symptom provocation study. Neuropsychopharmacology, 1999; 21:40-50.
  76. Liberzon I, Lopez J, Vazquez D, Flagel SB, & Young EA: Differential regulation of hippocampal glucocorticoid receptors and negative feedback: relevance to PTSD. Journal of Neuroendocrinology, 1999; 11: 11-17.
  77. Liberzon I, Taylor SF, Amdur R, Jung TD, Chamberlain KR, Minoshima S, Koeppe RA, & Fig LM: Brian activation in PTSD in response to trauma-related stimuli. Biological Psychiatry, 1999; 45:817-826.
  78. Abelson JL: Hypothalamic-pituitary-adrenal axis activity in psychiatric disorders: Focus on panic disorder. Essential Psychopharmacology, 1998; 2:331-350.
  79. Albucher RC, Abelson JL, & RM Nesse. Defense mechanism changes in successfully treated patients with obsessive-compulsive disorder. American Journal of Psychiatry, 1998. 155(4):558-9.
  80. Huang MP, Rajarethinam RP, Abelson JL, & Alessi NE: Case studies of the Internet: Experiences at an Anxiety Disorders Program. MD Computing, 1998; 15:238-241.
  81. Young EA, Nesse RM, Weder A, & Julius S: Anxiety and cardiovascular reactivity in the Tecumseh population. Journal of Hypertension, 1998; 16:1727-1733.
  82. Kales HC, Abelson JL, & Riba MB:  The relevance of transference during medication management: A case of erotized transference.  Jefferson Journal of Psychiatry, 1998; 14:30-40.
  83. Goldfinger D, Amdur R, & Liberzon I: Psychophysiologic responses to the Rorschach in PTSD patients, non-combat and combat controls. Depression and Anxiety, 1998; 8:104-111.
  84. Goldfinger D, Amdur R, & Liberzon I:  Rorschach in Vietnam Veterans with PTSD, normal and combat controls. Depression and Anxiety, 1998; 8:112-120.
  85. Casada J, Amdur RL, & Liberzon I: Psychophysiologic assessment of PTSD: general hyperresponsivness vs. trauma specificity. Biological Psychiatry, 1998; 44(10):1037-1045.
  86. Taylor SF, Liberzon I,  Fig LM, & Koeppe RA:  The effect ofemotional content on visual recognition memory: A PET activation study. Neuroimage, 1998; 8:188-197.
  87. Hanna GL, Himle JA, Koram DQ, Veenstra-Vander Weele J, Leventhal BL, & Cook EH: Serotonin transporter and seasonal variation in blood serotonin in families with obsessive-compulsive disorder. Neuropsychopharmacology, 1998; 18:102-111.
  88. Fischer DJ, Himle JA, & Hanna GL:  Group behavioral therapy for adolescents with obsessive-compulsive disorder: Preliminary outcomes.  Research on Social Work Practice, 1998; 8:629-636.
  89. Fischer DJ, Himle JA, & Hanna GL: Symptom profiles of adult versus childhood OCD. Depression and Anxiety, 1997; 4:237-239.
  90. Young EA, Abelson JL, Curtis GC, & Nesse RM: Childhood adversity and vulnerability to mood and anxiety disorders. Depression, 1997; 5:66-72.
  91. Curtis GC, Abelson JL, & Gold PW: ACTH and cortisol responses to CRH: Changes in panic disorder and effects of alprazolam treatment.  Biol Psychiatry, 1997; 41:76-85.
  92. Liberzon I, Taylor SF, Fig LM, & Koeppe RA: Alteration of thalamo cortical perfusion ratio during PTSD flashback. Depression and Anxiety, 1997; 4:146-150.
  93. Liberzon I, Krstov M, & Young EA: Stress-Restress: Effects on ACTH and fast feedback.  Psychoneuroendocrinology. 1997; 22(6):443-453.
  94. Liberzon I and Young EA: Effects of stress and glucocorticoids on CNS oxytocin receptors binding.  Psychoneuroendocrinology, 1997; 22:411-422.
  95. Liberzon I,  Trujillo KA, Akil H, & Young EA:  Motivational properties of oxytocin  in conditioned place preference paradigm.  Neuropsychopharmacology, 1997; 17:353-359.
  96. Abelson JL and Curtis GC: Hypothalamic-Pituitary-Adrenal Axis Activity in Panic Disorder: 24-Hour Secretion of Adrenocorticotropin and Cortisol. Archives of General Psychiatry, 1996; 53:323-331.
  97. Abelson JL and Curtis GC: Hypothalamic-Pituitary-Adrenal Axis Activity in Panic Disorder: Pre-Treatment Cortisol Predicts Long-Term Outcome. American Journal of Psychiatry, 1996; 153:1:69-73.
  98. Amdur R and Liberzon I: Dimensionality of Dissociation in Subjects with PTSD. Dissociation, 1996; 9: 118-124.
  99. Wittchen H-U, Zhao S, Abelson JM, Abelson JL, & Kessler RC: Reliability and procedural validity of UM-CIDI DSM-III-R phobic disorders. Psychol Med, 1996; 26:1169-1177.
  100. Abelson JL, Weg JG, Nesse RN, & Curtis, GC: Neuroendocrine responses to laboratory panic: Cognitive intervention in the doxapram model. Psychoneuroendocrinology, 1996; 21(4):375-90.
  101. Abelson JL, Nesse RM, Weg, JG, & Curtis GC: Respiratory Psychophysiology and Anxiety: Cognitive Intervention in the Doxapram Model of Panic. Psychosomatic Medicine, 1996; 58:302-313.
  102. Cameron OG, Smith CB, Nesse RM, Hill EM, Hollingsworth PJ, Abelson JL, Hariharan M, & Curtis GC: Platelet Alpha2-Adrenoreceptors, Catecholamines, Hemodynamic Variables, and Anxiety in Panic Patients and Their Asymptomatic Relatives. Psychosomatic Medicine, 1996; 58:289-301.
  103. Abelson JL, Curtis GC, Cameron OG: Hypothalamic-pituitary-adrenal axis activity in panic disorder: Effects of alprazolam on 24-hour secretion of adrenocorticotropin and cortisol.  J Psychiat Res, 1996; 30:79-93.
  104. Abelson JL and Curtis GC:  Hypothalamic-pituitary-adrenal axis activity in panic disorder: Prediction of long-term outcome by pre-treatment cortisol levels.  Am J Psychiatry, 1996; 153:69-73.
  105. Ronis D, Bates EW, Garfein AJ, Buit BK, Falcon SP, and Liberzon I:  Longitudinal patterns of care for patients with Posttraumatic Stress Disorder. Journal of Traumatic Stress, 1996; 9: 763 – 781.
  106. Thyer B A, Himle J. & Santa C: Applied behavior analysis in social and community action. Behaviorists for Social Action Journal, 1996; 5:14-16.
  107. Nesse RM and Abelson JL: Natural selection and fear regulation mechanisms. Behavioral and Brain Sciences, 1995; 18(2):309-310.
  108. Schweitzer PB, Nesse RM, Fantone RF, & Curtis GC: Outcomes of Group Cognitive and Behavioral Training in the Treatment of Panic Disorder and Agoraphobia. Journal of the American Psychiatric Nurses Association, 1995; 1:3:83-90.
  109. Abelson JL: Cholecystokinin in psychiatric research: A time for cautious excitement (review/editorial). J Psychiat Res, 1995; 29:389-396.
  110. Abelson JL, Curtis GC, Nesse R.M., Fantone R, Pyke RE, & Bammert-Adams J.: The Effects of Central Cholecystokinin Receptor Blockade on Hypothalamic-Pituitary-Adrenal and Symptomatic Responses to Overnight Withdrawal from Alprazolam. Biological Psychiatry, 1995; 37:56-59.
  111. Thyer BA, Himle J, Curtis GC, Cameron OG & Nesse RM: A comparison of panic disorder and agoraphobia with panic attacks. Comprehensive Psychiatry, 1995; 26:208-214.
  112. Himle JA, Bordnick PS, & Thyer BA: A comparison of trichotillomania and obsessive-compulsive disorder. Journal of Psychopathology and Behavioral Assessment, 1995; 17:51-260.
  113. Abelson JL, Nesse RM, Vinik I, & Aaron I: Pentagastrin infusions in patients with panic disorder II Neuroendocrinology. Biological Psychiatry, 1994; 36:84-96.
  114. Abelson JL and Nesse RM: Pentagastrin infusions in patients with panic disorder I. Symptoms and cardiovascular responses. Biological Psychiatry, 1994; 36:73-83.
  115. Nesse RM: Computer emotions and mental software. Social Neuroscience Bulletin, 1994; 7(2): 36-37.
  116. Marks IM and Nesse RM: Fear and fitness: An evolutionary analysis of anxiety disorders. Ethology and Sociobiology, 1994; 15:247-261.
  117. Nesse RM: An evolutionary perspective on substance abuse. Ethology and Sociobiology, 1994; 15:339-348.
  118. Nesse RM and Klaas R: Risk perception by patients with anxiety disorder. Journal of Nervous and Mental Disease, 1994; 182:465-470.
  119. Taren JA, Curtis GC, & Gebarski SS: Late local and remote structural changes after capsulotomy for obsessive compulsive disorder. Stereotactic Functional Neurosurgery, 1994; 63:1-6.
  120. Cassano GB, Toni C, Petracca A, Deltito J, Benkert O, Curtis GC, Hippius H, Maier W, Shera D, & Klerman G: Adverse effects associated with the short-term treatment of panic disorder with imipramine, alprazolam or placebo. European Neuropsychopharmacology, 1994; 4:1:47-53.
  121. Himle JA: What is bashful bladder syndrome? Hospital Medicine, 1994; 30:55.
  122. Curtis GC, Massana J, Udina C, Ayuso JL, Cassano GB, & Perugi G: Maintenance Drug Therapy of Panic Disorder. Journal of Psychiatric Research, 1993; 27:suppl. 1:127-142.
  123. Curtis GC: Terapia De Mantenimiento Del Trastorno De Panico. Psiquiatria, 1993; 1:54-58.
  124. Abelson JL and Curtis GC: Discontinuation of Alprazolam After Successful Treatment of Panic Disorder: A Naturalistic Follow-up Study. J. Anxiety Disorders, 1993; 7:107-117.
  125. Lee YJ, Curtis GC, Weg JG, Abelson JL, Modell JG, & Campbell KM: Panic Attacks Induced by Doxapram. Biology Psychiatry, 1993; 33:295-297.
  126. Abelson JL and Alessi NE: Discussion of "Child Panic Revisited". J Am Acad Child Adol Psychiatry, 1992; 31:114-116.
  127. Abelson JL, Glitz D, Cameron OG, Lee MA, Bronzo M, & Curtis GC: Endocrine, Cardiovascular, and Behavioral Responses to Clonidine in Patients with Panic Disorder. Biological Psychiatry, 1992; 32:18-25.
  128. Cross-National Collaborative Panic Study, Second Phase Investigators: Drug Treatment of Panic Disorder. Comparative Efficacy of Alprazolam, Imipramine, and Placebo. British Journal of Psychiatry, 1992; 160:191-202.
  129. Thyer BA, Himle JA, & Schweitzer PB: Birth order and obsessive-compulsive disorder. Anxiety Practice Journal, 1992; 1:9-34.
  130. Curtis GC: PET Findings in Panic, Anxiety, and Phobic Disorders. Annals of Clinical Psychiatry, 1991; 3:2:111-14.
  131. Abelson JA, Nesse RM, & Vinik A: Stimulation of corticotrophin release by pentagastrin in normal subjects and patients with panic disorder. Biological Psychiatry, 1991; 29:1220-1223.
  132. Krone KP, Himle JA, & Nesse RM: A standardized behavioral group treatment program for obsessive-compulsive disorder: preliminary outcomes. Behavior Research and Therapy, 1991; 29:627-631.
  133. Abelson JL, Glitz D, Cameron OG, Lee MA, Bronzo M, & Curtis GC: Blunted Growth Hormone Response to Clonidine in Patients with Generalized Anxiety Disorder. Archives of General Psychiatry, 1991; 48:157-162.
  134. Himle J, Crystal D, Curtis GC, & Fluent TE: Mode of onset of simple phobias: further evidence of heterogeneity. Psychiatry Research, 1991; 36:37-431.
  135. Himle J & Hill E.: Alcohol abuse and the anxiety disorders. Journal of Anxiety Disorders, 1991; 5:237-245.
  136. Panzer MJ, DeQuardo JR, & Abelson JL:  Delayed diagnosis of a frontal meningioma.  Annals of Clinical Psychiatry, 1991; 3:259-262.
  137. Abelson JA, Nesse RM, & Vinik A: Treatment of panic-like attacks with a long-acting analogue of somatostatin. Journal of Clinical Psychopharmacology, 1990; 10: 128-132.
  138. Nesse RM: Evolutionary explanations of emotions. Human Nature, 1990; 261-289.
  139. Starkman MN, Cameron OG, Nesse RM, & Zelnik T: Peripheral catecholamine levels and the symptoms of anxiety: studies in patients with and without pheochromocytoma. Psychosomatic Medicine, 1990; 52:129-142.
  140. Cameron OG, Smith CB, Lee MA, Hollingsworth PJ, Hill EM, & Curtis GC: Adrenergic Status in Anxiety Disorders: Platelet Alpha2-Adrenergic Receptor Binding, Blood Pressure, Pulse and Plasma Catecholamines in Panic and Generalized Anxiety Disorder Patients and in Normal Subjects, Biological Psychiatry, 1990; 28:3-20.
  141. Lee MA, Cameron OG, Gurguis GNM, Glitz DA, Smith CB, Hariharan M, Abelson JL, & Curtis GC: Alpha2-Adrenoreceptor Status in Obsessive-Compulsive Disorder. Biological Psychiatry, 1990; 27:1083-1093.
  142. Mountz JM, Modell JG, Wilson M, Curtis GC, Lee MA, Schmaltz S, & Kuhl DE: Positron Emission Tomographic Evaluation of Cerebral Blood Flow During State-Anxiety in Simple Phobia. Archives of General Psychiatry, 1989; 46:501-504.
  143. Himle JA, McPhee KM, Cameron OG, & Curtis GC: Simple Phobia: Evidence for Heterogeneity. Psychiatry Research, 1989; 28:25-30.
  144. Modell JG, Himle J, Nesse RM, Mountz JM, & Schmaltz S: Sequential trials of fluoxetine, phenelzine, and tranylcypromine in the treatment of obsessive-compulsive disorder. Journal of Anxiety Disorders, 1989; 3:287-293.
  145. Modell JG, Mountz JM, Curtis GC, & Greden JF: Neurophysiologic Dysfunction in Basal Ganglia/Limbic Striatal and Thalamocortical Circuits as a Pathogenetic Mechanism of Obsessive-Compulsive Disorder. Journal of Neuropsychiatry, 1989; 1:1:27-36.
  146. Hariharan M, VanNoord T, Cameron OG, Curtis GC, Ostrow DG, & Greden JF: Free 3-Methoxy-4-hydroxphenylglycol Determined in Plasma by Liquid Chromatography with Coulometric Detection. Clin. Chem., 1989; 35:2:202-205.
  147. Himle J & Thyer BA: Clinical social work and obsessive-compulsive disorder. Behavior Modification, 1989; 13:459-470.
  148. Modell J G, Himle J, & Schmaltz S.: Sequential trials of fluoxetine, phenelzine, and tranylcypromine in the treatment of obsessive-compulsive disorder. Journal of Anxiety Disorders, 1989; 3:287-293.
  149. Thyer BA, Himle J, & Miller-Gogoleski MA: Parental death is not a precursor to panic disorder: Acommunity based replication. Phobia Practice and Research Journal, 1989; 2:29-36.`
  150. Himle J, Himle DP & Thyer BA: Irrationality and the anxiety disorders. Journal of Rational Emotive and Cognitive Behavior Therapy, 1989; 7:155-165.
  151. Hanna GL, Himle JA, Koram DQ, Veenstra-Vander Weele J, Leventhal BL, & Cook EH: Serotonin transporter and seasonal variation in blood serotonin in families with obsessive-compulsive disorder. Neuropsychopharmacology, 1989; 18:102-111.
  152. Abelson JL and Curtis GC:  Cardiac and neuroendocrine responses to exposure therapy in height phobics: Desynchrony within the "physiological response system".  Behav Res Ther, 1989; 27:561-567.
  153. Green MA and Curtis GC, Personality Disorders in Panic Patients: Response to Termination of Anti-panic Medication. Journal of Personality Disorders, 1988; 2:(4): 303-314.
  154. Cameron OG, Kuttesch D, McPhee K, & Curtis GC: Menstrual Fluctuation in the Symptoms of Panic Anxiety. Journal of Affective Disorders, 1988; 15:169-174.
  155. Gurgis NM, Cameron OG, Ericson WA, &Curtis GC: The Daily Distribution of Panic Attacks. Compr. Psychiatry, 1988; 29:1-3.
  156. Nesse RM: Panic disorder: An evolutionary view. Psychiatric Annals, 1988; 18:8:478-483.
  157. Cameron OG, Nesse RM: Systemic hormonal and physiological abnormalities in anxiety disorders: A review. Psychoneuroendocrinology, 13:287-307, 1988.
  158. Thyer BA, Himle J & Fischer D: Is parental death a selective precursor to either panic disorder or agoraphobia? A test of the separation anxiety hypothesis. Journal of Anxiety Disorders, 1988; 2:333-338.
  159. Himle J, Thyer BA & Fischer DJ: Prevalence of smoking among anxious outpatients. Phobia Practice and Research Journal, 1988; 1:25-31.
  160. Nesse RM: An evolutionary perspective on panic disorder and agoraphobia. Ethology and Sociobiology, 1987; 8:73S-83S.
  161. Cameron OG, Lee MA, Curtis GC, & McCann D: Endocrine and Physiological Changes during "Spontaneous" Panic Attacks. Psychoneuroendocrinology, 1987; 12:5:321-331.
  162. Cameron OG, Liepman MR, Curtis GC, & Thyer BA: Ethanol Retards Desensitization of Phobias in Non-Alcoholics. Br. J. Psychiatry, 1987; 150:845-849.
  163. Cameron OG, Curtis GC, Zelnik T, McCann D, Roth T, Guire K, & Huber-Smith M: Circadian Fluctuation of Plasma Epinephrine in Supine Humans. Psychoneuroendocrinology, 1987; 12:41-51.
  164. Thyer BA & Himle J: Phobic and Panic anxiety: how do they differ? Journal of Anxiety Disorders, 1987; 1:59-67.
  165. Cameron OG, Kerber K, & Curtis GC: Obsessive-Compulsive Disorder and the DST. (Letter) Psychiatry Research, 1986; 19: 329-330.
  166. Cameron OG, Thyer BA, Fechner S, Nesse RM, & Curtis GC: Behavior Therapy of Phobias: Predictors of Outcome. (Letter) Psychiatry Research, 1986; 19:245-246.
  167. Nesse R M, Curtis GC, Cameron OG, & Lee MA: Normal Intense Fear in Panic Disorder or Agoraphobic patients on Antipanic Medication. (Letter) Am. J. Psychiatry, 1986; 143:7.
  168. Huber-Smith MJ, Nesse RM, Maxhan M, & McCann D: Evaluation of plasma 3-methoxy-4-hydroxyphenylglycol (MHPG). Journal of Chromatography, 1986; 377:91-99.
  169. Thyer BA, Nesse RM, Curtis GC, & Cameron OG: Panic Disorder: A Test of the Separation Anxiety Hypothesis. Behav. Res. Ther., 1986; 24:209-211.
  170. Pegeron JP, Curtis GC, & Thyer BA: Simple Phobia Leading to Suicide: A Case Report. The Behavior Therapist, 1986; 9:134-135.
  171. Cameron OG, Thyer BA, Nesse RM, & Curtis GC: Symptom Profiles of Patients with DSM-III Anxiety Disorders. Am. J. Psychiatry, 1986; 143:1132-1137.
  172. Thyer B T, Parrish R T, Himle J, Cameron OG, Curtis GC, & Nesse RM: Alcohol Abuse among Clinically Anxious Patients. Behav. Res Ther., 1986; 24:357-359.
  173. Thyer B A, Himle J & Santa C: Applied behavior analysis in social and community action. Behaviorists for Social Action Journal, 1986; 5:14-16.
  174. Thyer BA & Himle J:. Temporal relationship between panic attack onset and phobic avoidance in agoraphobia. Behaviour Research and Therapy, 1985; 23:607-608.
  175. Thyer BA and Curtis GC: On the Diphasic Nature of Vasovagal Fainting Associated with Blood-Injury-Illness Phobia. Pav. J. Biol. Sci., 1985; 20:84-87.
  176. Thyer B, Tomlin P, Curtis G, Cameron O, & Nesse R: Diagnostic and Gender Differences in the Expressed Fears of Anxious Patients. J. Behav. Ther. Exp. Psychiatry, 1985; 16:111-115.
  177. Thyer BA, Himle J, Curtis GC: Blood Injury-Illness Phobia: A Review: J. Clin. Psychol., 1985; 41:451-459.
  178. Falcon S, Ryan C, Chamberlain K, & Curtis G: Tricyclics: Possible Treatment for Post Traumatic Stress Disorder. J. Clin. Psychiatry, 1985; 46:385-388.
  179. Nesse RM, Curtis GC, Thyer BA, McCann DS, Huber-Smith MJ, & Knopf RF: Endocrine and Cardiovascular Responses During Phobic Anxiety. Psychosom. Med., 1985; 47:320-332.
  180. Thyer B, Nesse R, Cameron O, & Curtis GC: Agoraphobia: A Test of the Separation Anxiety Hypothesis. Behav. Res. Ther., 1985; 23:75-78.
  181. Nesse RM, Cameron OG, Buda AJ, McCann DS, Curtis GC, & Huber-Smith MJ: Urinary Catecholamines and Mitral Valve Prolapse in Panic-Anxiety Patients. Psychiatry Research, 1985; 14:57-74.
  182. Rainey JR and Nesse RM: Psychobiology of anxiety and anxiety disorders. In Psychiatric Clinics of North America, Vol 8, pp. 133-144, 1985. Curtis GC, Thyer BA, Rainey J (eds); Saunders, Philadelphia.
  183. Starkman MN, Zelnik T, Nesse RM, & Cameron OC: Anxiety in patients with pheochromocytoma. Archives of Internal Medicine, 1985; 145:248-252.
  184. Thyer BA, Himle J, Curtis GC, Nesse RM, & Cameron OG: Ages of Onset of DSM-III Anxiety Disorders. Compr. Psychiatry, 1985; 26:113-122.
  185. Thyer BA, Himle J, Curtis GC, Cameron OG, & Nesse RM: A Comparison of Panic Disorder and Agoraphobia with Panic Attacks. Compr. Psychiatry, 1985; 26:208-214.
  186. Thyer BA, Himle J & Curtis GC: Blood-injury-illness phobia: a review. Journal of Clinical Psychology, 1985; 41:451-459.
  187. Cameron OG, Smith CB, Hollingsworth PJ, Nesse RM, & Curtis GC: Platelet Alpha-2-Adrenoreceptor Binding and Plasma Catecholamines Before and During Imipramine Treatment In Patients With Panic Anxiety. Arch. Gen. Psychiatry, 1984; 41:1144-1148.
  188. Thyer B and Curtis GC: The Effects of Ethanol Intoxication on Phobic Anxiety. Behav. Res. and Ther., 1984; 22:556-610.
  189. Thyer BA and Curtis GC: Furosemide as an Adjuct to Exposure Therapy of Psychogenic Urinary Retention. Perceptual and Motor Skills, 1984; 59:114.
  190. Tomlin P, Thyer BA, Curtis GC, Nesse RM, Cameron OG, & Wright P: Standardization of the Fear Survey Schedule Based Upon Patients with DSM-III Anxiety Disorders. J. Behav. Ther. Exper. Psychiat., 1984; 15:123-126.
  191. Nesse RM, Cameron OG, Curtis GC, McCann DS, & Huber-Smith MJ: Adrenergic Function in Panic Anxiety Patients. Arch. Gen. Psychiatry, 1984; 41:771-776.
  192. Thyer B, Curtis GC. & Fechner S: Fear of Criticism Is Not Specific to Obsessive-Compulsive Disorder. Behav. Res. Ther., 1984; 22:77-80.
  193. Thyer BA and Curtis GC: The Repeated Pretest-Posttest Single-Subject Experiment: A New Design for Empirical Clinical Practice. J. Behav. Ther.Exp. Psychiat., 1983; 14:311-315.
  194. Curtis GC and Thyer B.: Fainting on Exposure to Phobic Stimuli. Am. J. Psychiatry, 1983; 140:771-774.
  195. Nesse R.M, Carli T, Curtis GC & Kleinman PD: Pseudohallucinations in Cancer Chemotherapy Patients. Am. J. Psychiatry, 1983; 140:483-485.
  196. Van Egeren LF, Abelson JL, & Sniderman LD: Interpersonal and electrocardiographic responses of Type A's and Type B's in competitive socioeconomic games.  J Psychosom Res, 1983; 27:53-59.
  197. Nesse RM, Curtis GC, & Brown GM: Phobic Anxiety Does Not Affect Plasma Levels of Thyroid Stimulating Hormone in Man. Psychoneuroendocrinology, 1982; 7:69-74.
  198. Curtis GC, Cameron OG, & Nesse RM: Dexamethasone Suppression Test in Panic Disorder and Agoraphobia. Am. J. Psychiatry, 1982; 39:1043-1046.
  199. Curtis GC: Sensory Experiences During Treatment of Phobias by in Vivo Exposure. Am. J. Psychiatry, 1981; 138:1094-1097.
  200. Nesse R, Carli T, Curtis GC, & Kleinman PD: Pretreatment Nausea in Cancer Chemotherapy: A Conditioned Response? Psychosom. Med., 1980; 42:33-36.
  201. Nesse R, Curtis GC, Brown GM, & Rubin RT: Anxiety Induced by Flooding Therapy for Phobias Does Not Elicit Prolactin Secretory Response. Psychosom. Med., 1980; 42:25-31.
  202. Curtis GC, Nesse R, Buxton M, & Lippman D: Plasma Growth Hormone: Effect of Anxiety During Flooding in Vivo. Am.J. Psychiatry, 1979; 136:410-414.
  203. Curtis GC, Nesse R, Buxton M, & Lippman D.: Anxiety and Plasma Cortisol at the Crest of the Circadian Cycle: Reappraisal of a Classical Hypothesis. Psychosom. Med., 1978; 40:368-378.
  204. Van Egeren LF, Abelson JL, & Thornton DW:  Cardiovascular consequences of expressing anger in a mutually dependent relationship.  J Psychosom Res, 1978; 22:537-548.
  205. Carroll B, Curtis GC, & Mendels J: Cerebrospinal Fluid and Plasma Free Cortisol Concentrations in Depression. Psychiatry Med, 1976; 6:235-244.
  206. Carroll B, Curtis GC, & Mendels J: Neuroendocrine Regulation in Depression (II): Discrimination of Depressed from Non-Depressed Patients. Arch. Gen. Psychiatry, 1976; 33:1051-1058.
  207. Carroll B, Curtis GC, & Mendels J: Neuroendocrine Regulation in Depression (I): Limbic System - Adrenal Cortical Dysfunction. Arch. Gen. Psychiatry, 1976; 33:1039-1044.
  208. Carroll BJ & Curtis GC: Neuroendocrine Identification of Depressed Patients. Aust. NZ. J. Psychiat., 1976; 10:13-20.
  209. Carroll B, Curtis GC, Davies B, Mendels J, & Sugarman A: Urinary Free Cortisol Excretion in Depression. Psychol. Med., 1976; 6:43-50.
  210. Curtis GC, Buxton M, Lippman D, Nesse R, &  Wright J: "Flooding in Vivo" During the Circadian Phase of Minimal Cortisol Secretion: Anxiety and Therapeutic Success Without Adrenal Cortical Activation. Biol. Psychiatry, 1976; ll:101-107.
  211. Curtis GC; Nesse R; Buxton M, Wright J; & Lippman D: Flooding, InVivo, as Research Tool and Treatment Method for Phobias. A Preliminary Report. Compr. Psychiatry, 1976; 17:153-160.